Gokal R, Baillod R, Bogle S, Hunt L, Jakubowski C, Marsh F, Ogg C, Oliver D, Ward M, Wilkinson R
Nephrol Dial Transplant. 1987;2(3):172-8.
In a multi-centre study by seven large renal units in the United Kingdom, the morbidity and mortality of all patients starting CAPD and haemodialysis during a 2-year period (1983-1984) has been monitored prospectively and related to reasons for choice of therapy and potential risk factors. Over this period 338 new patients (mean age 48; range 3-77 years) started CAPD; 17% had diabetes mellitus and 25% had cerebro/cardiovascular disease. One hundred and seventy-five patients (mean age 45; range 5-73 years) started haemodialysis; 6% had diabetes mellitus and 14% had cerebro/cardiovascular disease. The Kaplan-Meier actuarial patient survival estimates at 2 years were haemodialysis 84% and CAPD 83%, whilst technique survival figures for the same period were haemodialysis 92% and CAPD 80%. Cox's regression analysis showed that cerebro/cardiovascular disease and age greater than 60 years were most important predictors for survival in CAPD patients, in whom smoking appeared to be a significant risk factor, for permanent change of therapy to haemodialysis. The major cause of 'drop out' in both groups was transplantation, whilst hospitalisation was 14.9 days per patient year for CAPD and 12.8 for haemodialysis patients. Within the CAPD group a temporary change to haemodialysis (less than 2 months) occurred on 106 occasions (each of mean of 19 days duration), amounting to 10 days per patient year of therapy. CAPD was used twice as often as haemodialysis for managing new patients. After 2 years hospitalisation technique and patient survival were comparable in the two groups, with cerebro/cardiovascular disease, age, and smoking being significant predictors of outcome.
在英国七个大型肾脏单位开展的一项多中心研究中,对1983年至1984年这两年期间开始进行持续性非卧床腹膜透析(CAPD)和血液透析的所有患者的发病率和死亡率进行了前瞻性监测,并与治疗选择原因及潜在风险因素相关联。在此期间,338名新患者(平均年龄48岁;范围3至77岁)开始进行CAPD;17%患有糖尿病,25%患有脑血管/心血管疾病。175名患者(平均年龄45岁;范围5至73岁)开始进行血液透析;6%患有糖尿病,14%患有脑血管/心血管疾病。两年时采用Kaplan-Meier法计算的患者精算生存率估计值为:血液透析84%,CAPD 83%,而同期的技术生存率数据为:血液透析92%,CAPD 80%。Cox回归分析表明,脑血管/心血管疾病和年龄大于60岁是CAPD患者生存的最重要预测因素,其中吸烟似乎是导致治疗永久性改为血液透析的一个重要风险因素。两组中“退出”的主要原因是移植,而CAPD患者每年每人的住院天数为14.9天,血液透析患者为12.8天。在CAPD组中,有106次临时改为血液透析(少于2个月)(每次平均持续19天),相当于每年每位患者的治疗时间中有10天。在管理新患者方面,CAPD的使用频率是血液透析的两倍。两年后,两组在住院治疗技术和患者生存方面具有可比性,脑血管/心血管疾病、年龄和吸烟是结果的重要预测因素。